Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
GeNeuro and Servier sign partnership to develop first medicine addressing a causal factor of multiple sclerosis
Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.
Laquinimod
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community.
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
US top court denies Israel's Teva Pharmaceuticals stay in Copaxone patent fight
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset.
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response.
A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (LIBRETTO)
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.
Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.
Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
Vitamin D receptor binding, chromatin states and association with multiple sclerosis.

Pages